{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:35:48Z","timestamp":1789605348140,"version":"build-2803163510"},"reference-count":150,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jtcvs.2025.04.009","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T09:01:51Z","timestamp":1746349311000},"page":"884-901.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The 2025 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of esophageal and gastroesophageal junction cancer"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-4473","authenticated-orcid":false,"given":"Daniela","family":"Molena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-2188","authenticated-orcid":false,"given":"Marisa","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve B.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Worrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Neng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Enzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Kleinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudish","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Palta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos E.","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishindra M.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic E.","family":"Sanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Sihag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2025.04.009_bib1","volume":"2","year":"2024"},{"issue":"8","key":"10.1016\/j.jtcvs.2025.04.009_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00268-004-7417-1","article-title":"Improved prognosis of resected esophageal cancer","volume":"28","author":"Stein","year":"2004","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1053\/j.gastro.2019.09.051","article-title":"AGA clinical practice update on endoscopic treatment of Barrett's esophagus with dysplasia and\/or early cancer: expert review","volume":"158","author":"Sharma","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jtcvs.2025.04.009_bib5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.jtcvs.2025.04.009_bib6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11912-021-01153-4","article-title":"Update on management of squamous cell esophageal cancer","volume":"24","author":"Waters","year":"2022","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jtho.2016.10.002","article-title":"Final results of NRG oncology RTOG 0246: an organ-preserving selective resection strategy in esophageal cancer patients treated with definitive chemoradiation","volume":"12","author":"Swisher","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.gie.2023.03.030","article-title":"American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence","volume":"98","author":"Al-Haddad","year":"2023","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"10.1016\/j.jtcvs.2025.04.009_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S2468-1253(23)00243-1","article-title":"Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial","volume":"8","author":"Reynolds","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.athoracsur.2017.01.020","article-title":"The American Association for Thoracic Surgery\/Society of Thoracic Surgeons Position Statement on developing clinical practice documents","volume":"103","author":"Bakaeen","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"7650","key":"10.1016\/j.jtcvs.2025.04.009_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib13","series-title":"AJCC Cancer Staging Manual","first-page":"185","year":"2017"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.gie.2013.08.005","article-title":"Endotherapy versus surgery for early neoplasia in Barrett's esophagus: a meta-analysis","volume":"79","author":"Wu","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/SLA.0000000000004038","article-title":"Is local endoscopic resection a viable therapeutic option for early clinical stage T1a and T1b esophageal adenocarcinoma? A propensity-matched analysis","volume":"275","author":"Kamarajah","year":"2022","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2013.11.006","article-title":"Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus","volume":"146","author":"Pech","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.gie.2010.10.046","article-title":"Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases","volume":"73","author":"Pouw","year":"2011","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.gie.2014.08.025","article-title":"Diagnostic performance of EUS in predicting advanced cancer among patients with Barrett's esophagus and high-grade dysplasia\/early adenocarcinoma: systematic review and meta-analysis","volume":"81","author":"Qumseya","year":"2015","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/a-1380-8899","article-title":"Favorable effect of endoscopic reassessment of clinically staged T2 esophageal adenocarcinoma: a multicenter prospective cohort study","volume":"54","author":"van de Ven","year":"2022","journal-title":"Endoscopy"},{"issue":"6 suppl","key":"10.1016\/j.jtcvs.2025.04.009_bib20","first-page":"S3","article-title":"The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002","volume":"58","year":"2003","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib21","first-page":"6","article-title":"Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study)","volume":"46","author":"Manner","year":"2014","journal-title":"Endoscopy"},{"issue":"10","key":"10.1016\/j.jtcvs.2025.04.009_bib22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/00042737-200210000-00009","article-title":"Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach","volume":"14","author":"May","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jtcvs.2025.04.009_bib23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/gut.2007.142539","article-title":"Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus","volume":"57","author":"Pech","year":"2008","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.04.009_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/gut.2010.229310","article-title":"Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial","volume":"60","author":"van Vilsteren","year":"2011","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/gutjnl-2015-309298","article-title":"Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)","volume":"65","author":"Phoa","year":"2016","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.gie.2022.02.016","article-title":"Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry","volume":"96","author":"Wolfson","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.14309\/ajg.0000000000001539","article-title":"Hybrid APC in combination with resection for the endoscopic treatment of neoplastic barrett's esophagus: a prospective, multicenter study","volume":"117","author":"Knabe","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gutjnl-2020-322615","article-title":"Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation \u00b1 endoscopic resection: results from the national Dutch database in a 10-year period","volume":"71","author":"van Munster","year":"2022","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.gie.2009.02.006","article-title":"An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients","volume":"70","author":"Dumot","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"10.1016\/j.jtcvs.2025.04.009_bib30","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.14309\/ajg.0000000000000822","article-title":"Multifocal cryoballoon ablation for eradication of Barrett's esophagus-related neoplasia: a prospective multicenter clinical trial","volume":"115","author":"Canto","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.gie.2017.10.011","article-title":"Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer","volume":"87","author":"Wani","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"20","key":"10.1016\/j.jtcvs.2025.04.009_bib32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4253\/wjge.v8.i20.763","article-title":"Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection","volume":"8","author":"Ballard","year":"2016","journal-title":"World J Gastrointest Endosc"},{"issue":"12","key":"10.1016\/j.jtcvs.2025.04.009_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doab034","article-title":"Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvement","volume":"34","author":"van der Wel","year":"2021","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11605-015-3009-7","article-title":"Inter-observer variability in the interpretation of endoscopic mucosal resection specimens of esophageal adenocarcinoma: interpretation of ER specimens","volume":"20","author":"Worrell","year":"2016","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.04.009_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/gutjnl-2019-318985","article-title":"Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology","volume":"69","author":"van der Wel","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/SLA.0000000000001702","article-title":"Traveling to a high-volume center is associated with improved survival for patients with esophageal cancer","volume":"265","author":"Speicher","year":"2017","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.jtcvs.2025.04.009_bib37","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1007\/s00464-021-08884-2","article-title":"Long-term outcomes of endoscopic mucosal resection for early-stage esophageal adenocarcinoma","volume":"36","author":"Oza","year":"2022","journal-title":"Surg Endosc"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.04.009_bib38","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1097\/JS9.0000000000000427","article-title":"Efficacy of endoscopic therapy for T1b esophageal cancer and construction of prognosis prediction model: a retrospective cohort study","volume":"109","author":"Fan","year":"2023","journal-title":"Int J Surg"},{"issue":"9","key":"10.1016\/j.jtcvs.2025.04.009_bib39","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ueg2.12151","article-title":"Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma","volume":"9","author":"van de Ven","year":"2021","journal-title":"United European Gastroenterol J"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib40","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00464-023-10565-1","article-title":"Construction and validation of a risk-scoring model to predict lymph node metastasis in T1b-T2 esophageal cancer","volume":"38","author":"Lin","year":"2024","journal-title":"Surg Endosc"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib41","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jtcvs.2020.10.138","article-title":"Defining low-risk lesions in early-stage esophageal adenocarcinoma","volume":"162","author":"Sihag","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.04.009_bib42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.gie.2024.05.005","article-title":"Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Surveillance, Epidemiology, and End Results database","volume":"100","author":"Mohapatra","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11605-015-2950-9","article-title":"Can the risk of lymph node metastases be gauged in endoscopically resected submucosal esophageal adenocarcinomas? A multi-center study","volume":"20","author":"Boys","year":"2016","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/SLA.0b013e3181fbad42","article-title":"The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens","volume":"253","author":"Leers","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11605-016-3210-3","article-title":"Esophagectomy following endoscopic resection of submucosal esophageal cancer: a highly curative procedure even with nodal metastases","volume":"21","author":"Molena","year":"2017","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.suc.2021.03.004","article-title":"Recommendations for surveillance and management of recurrent esophageal cancer following endoscopic therapies","volume":"101","author":"Ekeke","year":"2021","journal-title":"Surg Clin North Am"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cgh.2017.10.024","article-title":"Surgical vs endoscopic management of T1 esophageal adenocarcinoma: a modeling decision analysis","volume":"16","author":"Chu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtho.2016.10.016","article-title":"Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer","volume":"12","author":"Rice","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.gie.2023.03.015","article-title":"American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations","volume":"98","author":"Forbes","year":"2023","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.gie.2022.03.005","article-title":"Analysis of metastases rates during follow-up after endoscopic resection of early \"high-risk\" esophageal adenocarcinoma","volume":"96","author":"Nieuwenhuis","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2409408","article-title":"Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer","volume":"392","author":"Hoeppner","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib52","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.athoracsur.2011.04.004","article-title":"Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease","volume":"92","author":"Stiles","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.athoracsur.2018.02.087","article-title":"Predictors of nodal metastases for clinical T2N0 esophageal adenocarcinoma","volume":"106","author":"Barbetta","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamasurg.2015.4068","article-title":"Association between clinically staged node-negative esophageal adenocarcinoma and overall survival benefit from neoadjuvant chemoradiation","volume":"151","author":"Gabriel","year":"2016","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.04.009_bib55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejso.2018.02.005","article-title":"Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: a population-based cohort study","volume":"44","author":"Goense","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.04.009_bib56","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.jtcvs.2018.01.006","article-title":"Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: a decision analysis","volume":"155","author":"Semenkovich","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib57","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.athoracsur.2019.04.008","article-title":"Neoadjuvant therapy vs upfront surgery for clinical T2N0 esophageal cancer: a systematic review","volume":"108","author":"Kidane","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib58","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.athoracsur.2023.04.014","article-title":"Gastric extent of tumor predicts peritoneal metastasis in Siewert II adenocarcinoma","volume":"117","author":"Mitchell","year":"2024","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/SLA.0000000000002040","article-title":"Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma","volume":"267","author":"Lee","year":"2018","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.jtcvs.2025.04.009_bib60","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1245\/s10434-016-5409-7","article-title":"Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer","volume":"23","author":"Ikoma","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.jtcvs.2025.04.009_bib61","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1007\/s00464-013-3058-5","article-title":"The incremental benefit of two quadrant lavage for peritoneal cytology at staging laparoscopy for oesophagogastric adenocarcinoma","volume":"27","author":"Munasinghe","year":"2013","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib63","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jtcvs.2025.04.009_bib64","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib65","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.jtcvs.2017.12.136","article-title":"Induction therapy for locally advanced distal esophageal adenocarcinoma: is radiation always necessary?","volume":"155","author":"Liou","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"18","key":"10.1016\/j.jtcvs.2025.04.009_bib66","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jtcvs.2025.04.009_bib67","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa2405195","article-title":"Preoperative chemoradiotherapy for resectable gastric cancer","volume":"391","author":"Leong","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib68","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/annonc\/mdw010","article-title":"A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction","volume":"27","author":"Klevebro","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib69","series-title":"Imfinzi-Based Regimen Demonstrated Statistically Significant and Clinically Meaningful Improvement in Event-Free Survival in Resectable Early-Stage Gastric and Gastroesophageal Junction Cancers","author":"Kemp","year":"2025"},{"issue":"11","key":"10.1016\/j.jtcvs.2025.04.009_bib70","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jamaoncol.2017.1598","article-title":"Effect of the addition of cetuximab to paclitaxel, cisplatin, and radiation therapy for patients with esophageal cancer: the NRG oncology RTOG 0436 phase 3 randomized clinical trial","volume":"3","author":"Suntharalingam","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.04.009_bib71","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bjc.2017.21","article-title":"Long-term results and recurrence patterns from SCOPE-1: a phase II\/III randomised trial of definitive chemoradiotherapy +\/\u2212 cetuximab in oesophageal cancer","volume":"116","author":"Crosby","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib72","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jtcvs.2025.04.009_bib73","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2217\/fon-2020-0969","article-title":"KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma","volume":"17","author":"Shah","year":"2021","journal-title":"Future Oncol"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib74","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(25)00027-0","article-title":"Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial","volume":"26","author":"van der Wilk","year":"2025","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.04.009_bib75","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/SLA.0000000000005798","article-title":"Waiting to operate: the risk of salvage esophagectomy","volume":"277","author":"Boerner","year":"2023","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.jtcvs.2025.04.009_bib76","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.annonc.2023.08.010","article-title":"Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial","volume":"34","author":"Nilsson","year":"2023","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.jtcvs.2025.04.009_bib77","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jtho.2019.04.004","article-title":"Detecting pathological complete response in esophageal cancer after neoadjuvant therapy based on imaging techniques: a diagnostic systematic review and meta-analysis","volume":"14","author":"de Gouw","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib78","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/j.gastro.2019.10.039","article-title":"Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer","volume":"158","author":"Azad","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib79","article-title":"Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers","volume":"6","author":"Huffman","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12885-018-4034-1","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial","volume":"18","author":"Noordman","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib81","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12885-023-10747-z","article-title":"A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of surgery as needed for oesophageal cancer-2","volume":"23","author":"van der Zijden","year":"2023","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.04.009_bib82","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/SLA.0000000000003636","article-title":"Active surveillance versus immediate surgery in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal cancer: a multicenter propensity matched study","volume":"274","author":"van der Wilk","year":"2021","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.jtcvs.2025.04.009_bib83","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/ijc.34417","article-title":"Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy","volume":"152","author":"Boerner","year":"2023","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib84","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13063-021-05274-w","article-title":"Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer","volume":"22","author":"Eyck","year":"2021","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.jtcvs.2025.04.009_bib85","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1470-2045(18)30201-8","article-title":"Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study","volume":"19","author":"Noordman","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.jtcvs.2025.04.009_bib86","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/01.JTO.0000437420.38972.fb","article-title":"Esophageal cancer recurrence patterns and implications for surveillance","volume":"8","author":"Lou","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib87","author":"Phase"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1200\/JCO.22.00686","article-title":"Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in localized deficient mismatch repair\/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma: the GERCOR NEONIPIGA phase II study","volume":"41","author":"Andr\u00e9","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib89","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1200\/JCO.2023.41.4_suppl.358","article-title":"INFINITY: a multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC\/GEJAC)","volume":"41","author":"Pietrantonio","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jtcvs.2025.04.009_bib90","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.22.01351","article-title":"Neoadjuvant pembrolizumab in localized microsatellite instability high\/deficient mismatch repair solid tumors","volume":"41","author":"Ludford","year":"2023","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.jtcvs.2025.04.009_bib91","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jtcvs.2025.04.009_bib92","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamaoncol.2016.6762","article-title":"Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial","volume":"3","author":"Smyth","year":"2017","journal-title":"JAMA Oncol"},{"issue":"35","key":"10.1016\/j.jtcvs.2025.04.009_bib93","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1200\/JCO.19.01124","article-title":"Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer","volume":"37","author":"Pietrantonio","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.04.009_bib94","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41379-019-0414-6","article-title":"Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes","volume":"33","author":"Hechtman","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib95","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1158\/1078-0432.CCR-19-1324","article-title":"Validation of microsatellite instability detection using a comprehensive plasma-based genotyping panel","volume":"25","author":"Willis","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"23","key":"10.1016\/j.jtcvs.2025.04.009_bib96","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/dote.12493","article-title":"Worldwide esophageal cancer collaboration: clinical staging data","volume":"29","author":"Rice","year":"2016","journal-title":"Dis Esophagus"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib97","first-page":"304","article-title":"Cancer of the esophagus and esophagogastric junction\u2014major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Rice","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib98","article-title":"Esophagectomy may have a role in stage IV esophageal adenocarcinoma","author":"Sewell","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib99","doi-asserted-by":"crossref","first-page":"LBA246","DOI":"10.1200\/JCO.2024.42.3_suppl.LBA246","volume":"42","author":"Janjigian","year":"2024","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","article-title":"Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study","volume":"25","author":"Shitara","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.jtcvs.2025.04.009_bib102","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","article-title":"Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 Trial","volume":"3","author":"Al-Batran","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib103","doi-asserted-by":"crossref","first-page":"LBA4001","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA4001","volume":"42","author":"Al-Batran","year":"2024","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.04.009_bib104","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.gassur.2024.03.031","article-title":"Survival in esophageal cancer with nonregional lymphadenopathy: a propensity score-matched analysis","volume":"28","author":"Tankel","year":"2024","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"10.1016\/j.jtcvs.2025.04.009_bib105","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ejso.2015.05.005","article-title":"Surgery in oesophago-gastric cancer with metastatic disease: treatment, prognosis and preoperative patient selection","volume":"41","author":"Schmidt","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib106","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1245\/s10434-023-14562-5","article-title":"Significance of surgery for resectable M1 lymph node metastases without organ metastasis in esophageal carcinoma in the era of neoadjuvant treatment","volume":"31","author":"Igaue","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib107","first-page":"109","article-title":"Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: a nationwide population-based cohort study","volume":"37","author":"Kroese","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib108","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1245\/s10434-019-08175-0","article-title":"Clinicopathologic characteristics of oligometastases from esophageal cancer and long-term outcomes of resection","volume":"27","author":"Ohkura","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib109","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0039-6060(98)70165-5","article-title":"Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan","volume":"123","author":"Kodama","year":"1998","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.04.009_bib110","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1285::AID-CNCR3>3.0.CO;2-R","article-title":"Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors","volume":"88","author":"Tajima","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.jtcvs.2025.04.009_bib111","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doaa032","article-title":"Prediction of lymph node metastasis in superficial esophageal squamous cell carcinoma in Asia: a systematic review and meta-analysis","volume":"33","author":"Xu","year":"2020","journal-title":"Dis Esophagus"},{"issue":"18","key":"10.1016\/j.jtcvs.2025.04.009_bib112","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2004.01.083","article-title":"Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer","volume":"22","author":"van Westreenen","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib113","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/cncr.10330","article-title":"Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma","volume":"94","author":"Kato","year":"2002","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jtcvs.2025.04.009_bib114","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju133","article-title":"Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer","volume":"106","author":"Merkow","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib115","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ajg.2013.8","article-title":"Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma","volume":"108","author":"Yamashina","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib116","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5090\/kjtcs.2020.53.4.168","article-title":"Adjuvant therapy for esophageal squamous cell carcinoma","volume":"53","author":"Sun","year":"2020","journal-title":"Korean J Thorac Cardiovasc Surg"},{"issue":"8","key":"10.1016\/j.jtcvs.2025.04.009_bib117","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/2050640619852260","article-title":"Outcomes of endoscopic submucosal dissection for early oesophageal squamous cell neoplasia at a Western centre","volume":"7","author":"Lorenzo","year":"2019","journal-title":"United European Gastroenterol J"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-2006-924993","article-title":"High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas","volume":"38","author":"Bollschweiler","year":"2006","journal-title":"Endoscopy"},{"issue":"11","key":"10.1016\/j.jtcvs.2025.04.009_bib119","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cgh.2019.05.045","article-title":"Clinical practice update on the utility of endoscopic submucosal dissection in T1b esophageal cancer: expert review","volume":"17","author":"Othman","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jtcvs.2025.04.009_bib120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.21037\/atm.2019.05.23","article-title":"Prognostic value of lymphovascular invasion in patients with esophageal squamous cell carcinoma","volume":"7","author":"Gu","year":"2019","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib121","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12876-024-03328-2","article-title":"Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study","volume":"24","author":"Tasaki","year":"2024","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.jtcvs.2025.04.009_bib122","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.21873\/anticanres.17127","article-title":"Optimizing therapeutic approaches in superficial esophageal cancer: reduced-volume radiotherapy and dose-dense chemotherapy after endoscopic resection","volume":"44","author":"Suzuki","year":"2024","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.09.019","article-title":"Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone","volume":"178","author":"Ohsawa","year":"2025","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.jtcvs.2025.04.009_bib124","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1245\/s10434-016-5416-8","article-title":"Prognostic significance of lymphovascular invasion for thoracic esophageal squamous cell carcinoma","volume":"23","author":"Wang","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.04.009_bib125","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1053\/j.gastro.2021.08.007","article-title":"Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma","volume":"161","author":"Kato","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib126","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2010.06.033","article-title":"Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906)","volume":"81","author":"Kato","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib127","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijrobp.2022.07.007","article-title":"A single-arm confirmatory study of definitive chemoradiation therapy including salvage treatment for clinical stage II\/III esophageal squamous cell carcinoma (JCOG0909 Study)","volume":"114","author":"Takeuchi","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.jtcvs.2025.04.009_bib128","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jjco\/hyh107","article-title":"Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)\/Japan Clinical Oncology Group trial (JCOG9516)","volume":"34","author":"Ishida","year":"2004","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jtcvs.2025.04.009_bib129","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/jjco\/hyp069","article-title":"A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708)","volume":"39","author":"Kato","year":"2009","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jtcvs.2025.04.009_bib130","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1007\/s00464-021-08768-5","article-title":"Long-term survival of patients with T1bN0M0 esophageal cancer after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter trial","volume":"36","author":"Nozaki","year":"2022","journal-title":"Surg Endosc"},{"issue":"13","key":"10.1016\/j.jtcvs.2025.04.009_bib131","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ejca.2015.05.027","article-title":"Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: chemoradiation followed by surgery versus chemoradiation alone","volume":"51","author":"Vincent","year":"2015","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib132","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/SLA.0000000000003397","article-title":"Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis","volume":"271","author":"Eyck","year":"2020","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.04.009_bib133","article-title":"Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience","volume":"33","author":"Mitchell","year":"2020","journal-title":"Dis Esophagus"},{"issue":"suppl 3","key":"10.1016\/j.jtcvs.2025.04.009_bib134","first-page":"S341","article-title":"Salvage esophagectomy","volume":"6 Suppl 3","author":"Hofstetter","year":"2014","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.21037\/acs.2017.03.02","article-title":"Salvage esophagectomy for persistent or recurrent disease after definitive chemoradiation","volume":"6","author":"Swisher","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"issue":"9","key":"10.1016\/j.jtcvs.2025.04.009_bib136","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/MNM.0000000000001229","article-title":"Role of 18F-FDG PET\/CT in restaging of esophageal cancer after curative-intent surgical resection","volume":"41","author":"Pande","year":"2020","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib137","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1186\/s12885-022-10345-5","article-title":"Surveillance strategy after curative resection for oesophageal squamous cell cancer using the hazard function","volume":"22","author":"Kanematsu","year":"2022","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib138","first-page":"1","article-title":"Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer","volume":"30","author":"Takebayashi","year":"2017","journal-title":"Dis Esophagus"},{"issue":"9","key":"10.1016\/j.jtcvs.2025.04.009_bib139","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/annonc\/mdw183","article-title":"Cervical esophageal cancer: a gap in cancer knowledge","volume":"27","author":"Hoeben","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.athoracsur.2012.10.028","article-title":"Salvage resections for recurrent or persistent cancer of the proximal esophagus after chemoradiotherapy","volume":"95","author":"Schieman","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib141","doi-asserted-by":"crossref","first-page":"85","DOI":"10.21873\/cdp.10183","article-title":"Clinical outcomes of definitive chemoradiotherapy for cervical esophageal cancer","volume":"3","author":"Tasaki","year":"2023","journal-title":"Cancer Diagn Progn"},{"issue":"8","key":"10.1016\/j.jtcvs.2025.04.009_bib142","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3748\/wjg.v10.i8.1098","article-title":"Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma","volume":"10","author":"Fu","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib143","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000012015","article-title":"Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus","volume":"57","author":"Stuschke","year":"1999","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.04.009_bib144","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.athoracsur.2022.12.015","article-title":"Recovery of patient-reported quality of life after esophagectomy","volume":"115","author":"Bonanno","year":"2023","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib145","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1038\/s41467-024-51271-3","article-title":"Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma","volume":"15","author":"Singh","year":"2024","journal-title":"Nat Commun"},{"issue":"35","key":"10.1016\/j.jtcvs.2025.04.009_bib146","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.20.01888","article-title":"Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer","volume":"38","author":"Kojima","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10294","key":"10.1016\/j.jtcvs.2025.04.009_bib147","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.04.009_bib148","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.athoracsur.2022.06.060","article-title":"Agreement between upper digestive disease app and provider evaluation of esophagectomy symptoms in a mobile app tool","volume":"116","author":"Traynor","year":"2023","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.jtcvs.2025.04.009_bib149","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.12598","article-title":"Association of mindfulness-based interventions with anxiety severity in adults with cancer: a systematic review and meta-analysis","volume":"3","author":"Oberoi","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtcvs.2025.04.009_bib150","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/SLA.0000000000006619","article-title":"Remote symptom monitoring in thoracic surgery patients after discharge","volume":"281","author":"Sewell","year":"2025","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.04.009_bib151","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jtcvs.2024.07.048","volume":"169","author":"Milojevic","year":"2025","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522325002983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522325002983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:04:53Z","timestamp":1783026293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522325002983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":150,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0022522325002983"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2025.04.009","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2025 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of esophageal and gastroesophageal junction cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2025.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}